UF-KURE19 Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UF-KURE19 Cells, covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas [Phase 1]